StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
GSK (GSK) Announces FDA Priority Review for BLA for Adult RSV Vaccine
November 2, 2022 8:37 AM
GSK (NYSE: GSK) announced that the US Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) and ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA